United Therapeutics Corporation
UTHR | NASDAQ
$594.74
-$3.98 (-0.66%)
Nov 2, 2026, 11:27 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.31B | 1.29B | 1.33B | 1.27B | 1.24B | 1.21B | 1.2B | 1.11B | 1.07B | 1.05B | 984.8M | 899.8M | 871.5M | 728.3M | 727.3M | 707.4M | 630.8M | 687.4M | 475.8M | 462.4M | 470.9M | 405.4M |
Depreciation & Amortization | 91.5M | 88.4M | 85.6M | 82.5M | 79.7M | 77.3M | 72.5M | 66.5M | 60.7M | 54.9M | 53.2M | 52.7M | 52.3M | 52.1M | 51.3M | 50.7M | 50.2M | 49.9M | 49.9M | 50.4M | 49.8M | 50M |
Stock-Based Compensation | 155.4M | 115.9M | 147.7M | 135.7M | 138.3M | 150.2M | 144M | 133.6M | 113M | 77.1M | 39.1M | 87.3M | 63.8M | 115.5M | 106.8M | 86.7M | 113.7M | 77.3M | 138.5M | 187.5M | 150.4M | 173.1M |
Other Working Capital | -151.6M | -185.8M | -80.9M | 5.7M | 13.9M | 41.6M | -12.9M | -22.2M | -62.5M | 7.9M | -25.7M | -46.5M | -30M | -96.4M | -106.1M | -68M | -118.4M | -56.1M | -125.4M | -111.6M | -66.3M | -21.4M |
Other Non-Cash Items | 71.3M | 120.1M | 2M | 33M | 27.4M | -4.4M | -24.3M | -26.7M | -22.8M | -17.6M | -1.3M | 9.6M | 27.5M | 74.6M | 58.3M | 90.6M | 106.7M | 67.7M | 108.2M | 29.8M | 11.3M | 13.2M |
Deferred Income Tax | 149.3M | 123.6M | 97.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -93.1M | -172M | -106.4M | 33.3M | -116.2M | -22M | -60.2M | -147.7M | -114.7M | -185.2M | -97.8M | -93.9M | -147.2M | -81.9M | -141.2M | -86.5M | -125.5M | -85.2M | -174.2M | -180.3M | -67.3M | -10.8M |
Operating Cash Flow | 1.69B | 1.56B | 1.56B | 1.56B | 1.37B | 1.41B | 1.33B | 1.14B | 1.11B | 979.7M | 978M | 955.5M | 867.9M | 888.6M | 802.5M | 848.9M | 775.9M | 797.1M | 598.2M | 549.8M | 615.1M | 630.9M |
Capital Expenditures | -592.2M | -546.4M | -520.5M | -434.3M | -300.3M | -283.2M | -246.5M | -238.5M | -227.7M | -227.3M | -230.4M | -191.2M | -194.3M | -166.6M | -138.8M | -169.9M | -124.4M | -123.7M | -120.8M | -62.5M | -55M | -56.9M |
Cash Acquisitions | n/a | n/a | n/a | -30M | -30M | -30M | -30M | -89.2M | -89.2M | -89.2M | -89.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.76B | -3.49B | -3.46B | -3.39B | -3.39B | -1.81B | -1.65B | -1.48B | -1.71B | -2.15B | -2.51B | -2.64B | -2.26B | -2.12B | -1.71B | -1.78B | -2.03B | -1.81B | -1.9B | -2.01B | -2.08B | -2.39B |
Sales Maturities Of Investments | 1.24B | 2.55B | 1.58B | 2.84B | 3.05B | 1.67B | 2.37B | 2.42B | 2.44B | 2.73B | 2.14B | 1.89B | 1.73B | 1.61B | 1.03B | 1.13B | 1.19B | 1.1B | 1.53B | 1.72B | 1.75B | 1.73B |
Other Investing Acitivies | 1.85B | 1.85B | 1.85B | 569M | -33.6M | -33.9M | -29M | -31.7M | -24.5M | -27.3M | -23M | -10.8M | -1.7M | 2M | 2M | -1.5M | 7.8M | n/a | n/a | n/a | -5.4M | 2.4M |
Investing Cash Flow | 744.5M | 357.1M | -551.3M | -446.9M | -702.7M | -482.8M | 417.2M | 582.5M | 384M | 236.8M | -719.6M | -951M | -731.6M | -673.4M | -811.5M | -818M | -959.9M | -839.8M | -486.9M | -354.9M | -390.7M | -717.2M |
Debt Repayment | 11.5M | -200M | -300M | -411.5M | -511.5M | -400M | -400M | -400M | -300M | -200M | -100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -2.56B | -2.5B | -1B | -1B | -700K | -12.2M | -1.01B | -1.01B | -1.01B | -1.01B | -27.3M | -27.2M | -27.3M | -13.8M | -11.4M | -11.6M | -11.5M | -11.7M | -10.8M | -10.7M | -10.6M | -10.5M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -37.5M | -97.6M | -54.6M | 4.6M | 41.4M | 110.1M | 157.4M | 139.1M | 110.6M | 85.3M | 115.4M | 163.6M | 163.1M | 124.9M | 62.9M | 15.1M | 24.6M | 35.4M | 55.6M | 54.1M | 43M | 53.9M |
Financial Cash Flow | -2.22B | -2.54B | -1.15B | -1.32B | -431.2M | -280.6M | -1.25B | -1.27B | -1.2B | -1.13B | -11.9M | 136.4M | 135.8M | 135M | 75.4M | 27.4M | 37M | 23.7M | 44.8M | 43.4M | 32.4M | 43.4M |
Net Cash Flow | 210.1M | -825.7M | -140.1M | -213.8M | 237.4M | 648.4M | 489.5M | 446.2M | 288.4M | 88M | 246.5M | 140.9M | 272.1M | 350.2M | 66.4M | 58.3M | -147M | -19M | 156.1M | 238.3M | 256.8M | -42.9M |
Free Cash Flow | 1.09B | 1.02B | 1.04B | 1.12B | 1.07B | 1.13B | 1.08B | 898.1M | 877.9M | 752.4M | 747.6M | 764.3M | 673.6M | 722M | 663.7M | 679M | 651.5M | 673.4M | 477.4M | 487.3M | 560.1M | 574M |
Adj. Free Cash Flow | 937.6M | 901M | 893M | 986.2M | 932.7M | 978.4M | 936.6M | 764.5M | 764.9M | 675.3M | 708.5M | 677M | 609.8M | 606.5M | 556.9M | 592.3M | 537.8M | 596.1M | 338.9M | 299.8M | 409.7M | 400.9M |
Maintenance CapEx | -380.28M | -378.45M | -375.22M | -259.81M | -86.53M | -64.16M | -44.79M | -37.43M | -48.74M | -48.74M | -70.17M | -53.23M | -67.55M | -75.95M | -54.52M | -105.46M | -66.7M | -58.3M | -59.64M | -1.34M | -17.14M | -35.34M |
Growth CapEx | -211.92M | -167.95M | -145.28M | -174.49M | -213.77M | -219.04M | -201.71M | -201.07M | -178.96M | -178.56M | -160.23M | -137.97M | -126.75M | -90.65M | -84.28M | -64.44M | -57.7M | -65.4M | -61.16M | -61.16M | -37.86M | -21.56M |
Owner Earnings | 1.3B | 1.18B | 1.19B | 1.3B | 1.28B | 1.35B | 1.28B | 1.1B | 1.06B | 930.96M | 907.83M | 902.27M | 800.35M | 812.65M | 747.98M | 743.44M | 709.2M | 738.8M | 538.56M | 548.46M | 597.96M | 595.56M |
Add to Watchlist
Select watchlists to add or remove UTHR